Cargando…
Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy
This study identifies BNIP3L as the key regulator of p53-dependent cell death mechanism in colon cancer cells targeted by the novel gallium based anticancer drug, KP46. KP46 specifically accumulated into mitochondria where it caused p53-dependent morphological and functional damage impairing mitocho...
Autores principales: | Wilfinger, Nastasia, Austin, Shane, Scheiber-Mojdehkar, Barbara, Berger, Walter, Reipert, Siegfried, Praschberger, Monika, Paur, Jakob, Trondl, Robert, Keppler, Bernhard K., Zielinski, Christoph C., Nowikovsky, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811457/ https://www.ncbi.nlm.nih.gov/pubmed/26517689 |
Ejemplares similares
-
NKP-1339, a first-in-class anticancer drug showing mild side effects and activity in patients suffering from advanced refractory cancer
por: Trondl, Robert, et al.
Publicado: (2012) -
FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors
por: Nguyen‐Dien, Giang Thanh, et al.
Publicado: (2023) -
BNIP3L/NIX regulates both mitophagy and pexophagy
por: Wilhelm, Léa P, et al.
Publicado: (2022) -
ULK1 promotes mitophagy via phosphorylation and stabilization of BNIP3
por: Poole, Logan P., et al.
Publicado: (2021) -
The outer mitochondrial membrane protein TMEM11 demarcates spatially restricted BNIP3/BNIP3L-mediated mitophagy
por: Gok, Mehmet Oguz, et al.
Publicado: (2023)